Sarepta Therapeutics, Inc. short interest in 2025
In 2025, Sarepta Therapeutics, Inc.'s disclosed short interest ran from 5.21% of shares outstanding on 15 Jan 2025 to 19.52% on 31 Dec 2025, a change of +14.31 percentage points. The year's high was 21.31% on 31 Jul 2025 and its low 5.08% on 14 Mar 2025, averaging 13.15% across 24 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 7.72 days on 31 Dec 2025. Full history: Sarepta Therapeutics, Inc..
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025 · 2026
2025 in figures
- Start of year
- 5.21% (15 Jan 2025)
- End of year
- 19.52% (31 Dec 2025)
- Change
- +14.31 pp
- High
- 21.31% (31 Jul 2025)
- Low
- 5.08% (14 Mar 2025)
- Average
- 13.15%
- Highest days to cover
- 7.72 (31 Dec 2025)
- SEC filings marked
- 8
Every report in 2025
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 15 Jan 2025 | 5.21% | 6.31 | results (8-K) |
| 31 Jan 2025 | 5.29% | 5.74 | |
| 14 Feb 2025 | 5.15% | 7.07 | |
| 28 Feb 2025 | 5.30% | 4.94 | results (8-K), 10-K filed |
| 14 Mar 2025 | 5.08% | 4.24 | |
| 31 Mar 2025 | 6.38% | 1.84 | |
| 15 Apr 2025 | 6.93% | 1.90 | |
| 30 Apr 2025 | 7.01% | 4.02 | |
| 15 May 2025 | 8.98% | 1.22 | 10-Q filed |
| 30 May 2025 | 9.43% | 2.35 | |
| 13 Jun 2025 | 10.06% | 3.09 | |
| 30 Jun 2025 | 14.94% | 1.25 | |
| 15 Jul 2025 | 15.12% | 3.54 | |
| 31 Jul 2025 | 21.31% | 1.00 | results (8-K) |
| 15 Aug 2025 | 18.67% | 1.64 | 10-Q filed |
| 29 Aug 2025 | 20.79% | 2.04 | |
| 15 Sep 2025 | 20.75% | 3.59 | |
| 30 Sep 2025 | 20.08% | 3.25 | |
| 15 Oct 2025 | 18.10% | 2.75 | |
| 31 Oct 2025 | 16.52% | 4.33 | |
| 14 Nov 2025 | 17.18% | 2.15 | results (8-K), 10-Q filed |
| 28 Nov 2025 | 18.67% | 5.33 | |
| 15 Dec 2025 | 19.23% | 6.34 | |
| 31 Dec 2025 | 19.52% | 7.72 |
See also: Sarepta Therapeutics, Inc.'s full history · most shorted US stocks of 2025 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.